Akman, AhmetAsena, LeylaOzturk, CanerGungor, Sirel Gur2021-02-282021-02-2820190886-3350http://hdl.handle.net/11727/5443Purpose: To evaluate the vision-related quality of life (QOL) after implantation of a new trifocal intraocular lens (IOL), by using the National Eye Institute Visual Function Questionnaire-14 (VF-14 QOL questionnaire). Setting: Baskent University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey. Design: Prospective noncomparative case series. Methods: Consecutive patients who had a new trifocal IOL (Pan-Optix) bilaterally implanted were included in the study. The vision-related QOL was assessed 3 months after the surgery in the second eye. The VF-14 QOL questionnaire was used, with a grading scale of 0, no difficulty; 1, a little difficulty; 2, moderate difficulty; 3, quite difficult; 4, impossible to perform. A subgroup of 14 patients, with an interval of at least 3 months between the surgery in the first eye and the surgery in the fellow eye, were also interviewed 3 months after the monocular IOL implantation. In this subgroup, the QOL with monocular and binocular implantation was compared. Results: The study comprised 48 patients. Reading small print, driving at night, and doing fine handwork were the most difficult tasks to perform, with the mean values of the VF-14 QOL questionnaire being 0.94 +/- 0.81 (SD), 0.89 +/- 0.68, and 0.64 +/- 0.67, respectively. Binocular implantation was associated with improvement in vision-related QOL when compared with monocular implantation, with significant differences in doing fine handwork such as sewing (P = .02) and using a computer (P = .03). Conclusions: With mean values of 1.00 or lower for each question, the results of the VF-14 QOL questionnaire indicated that patients who have the new trifocal IOL bilaterally implanted have an overall high satisfaction rate and a high vision-related QOL. (C) 2018 ASCRS and ESCRSenginfo:eu-repo/semantics/closedAccessOPTICAL BENCH PERFORMANCECATARACT-SURGERYVISUAL FUNCTIONOUTCOMESVF-14DISSATISFACTIONINDEXBENEFITSIMPACTarticle4521301340004583411000042-s2.0-85059349435